BACKGROUND: Acupuncture has become a viable option for migraine prophylaxis in Europe; however, despite its wide use, more data on the short- and long-term cost-effectiveness are needed when considering the perspectives of a paying third-party, the patient, and of society in general. The aim was to evaluate the cost and effectiveness of adjuvant acupuncture to pharmacologic treatment vs pharmacologic treatment alone in migraine patients after a 3-month acupuncture course and a 6-month follow-up from all perspectives. METHODS: The study involved an open-label randomized clinical trial of patients receiving acupuncture (n=42), and a waiting list control group (n=44). The number of migraine days during the last 28 days, as well as direct and indirect costs were considered. The trial was registered under DRKS00009803. RESULTS: The total cost per patient reached €696 vs €285 after 3 months of acupuncture and €66 vs €132 in the acupuncture and control groups after a 6-month follow-up, respectively (P=0.071). The trends observed in effectiveness and costs from all perspectives are discussed. CONCLUSION: The inclusion of acupuncture in health care results beneficial mainly for its observed trend in reduced losses of productivity and income, with the latter often exceeding the costs of acupuncture treatment. As such, acupuncture may be recommended as an adjuvant treatment in migraine prophylaxis to standard pharmacotherapy.

Czech Chinese Centre for Traditional Chinese Medicine University Hospital in Hradec Kralove Hradec Kralove Czech Republic

Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove Czech Republic

Faculty of Pharmacy in Hradec Kralove Charles University Hradec Kralove Czech Republic

Personal Social Services Research Unit Department of Health Policy London School of Economics and Political Science London UK

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China

Zobrazit více v PubMed

Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Cephalalgia. 2013;33(5):289–290. PubMed

Diluca M, Olesen J. The cost of brain diseases: a burden or a challenge? Neuron. 2014;82(6):1205–1208. PubMed

WHO Fact sheet: Headache disorders. [Accessed September 23, 2018]. Available from: http://www.who.int/mediacentre/factsheets/fs277/en/

Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;6(6):CD001218. PubMed PMC

Coeytaux RR, Befus D. Role of acupuncture in the treatment or prevention of migraine, tension-type headache, or chronic headache disorders. Headache. 2016;56(7):1238–1240. PubMed

Kim MR, Shin JS, Lee J, et al. Safety of acupuncture and pharmacopuncture in 80,523 musculoskeletal disorder patients: a retrospective review of internal safety inspection and electronic medical records. Medicine. 2016;95(18):e3635. PubMed PMC

Zhang J, Shang H, Gao X, Ernst E. Acupuncture-related adverse events: a systematic review of the Chinese literature. Bull World Health Organ. 2010;88(12):915–921. PubMed PMC

Macpherson H, Vertosick EA, Foster NE, et al. The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain. Pain. 2017;158(5):784–793. PubMed PMC

Kim SY, Lee H, Chae Y, Park HJ, Lee H. A systematic review of cost-effectiveness analyses alongside randomised controlled trials of acupuncture. Acupunct Med. 2012;30(4):273–285. PubMed

Ambrósio EM, Bloor K, Macpherson H. Costs and consequences of acupuncture as a treatment for chronic pain: a systematic review of economic evaluations conducted alongside randomised controlled trials. Complement Ther Med. 2012;20(5):364–374. PubMed

Deng ZQ, Zheng H, Zhao L, et al. Health economic evaluation of acupuncture along meridians for treating migraine in China: results from a randomized controlled trial. BMC Complement Altern Med. 2012;12:75. PubMed PMC

Evers S, Afra J, Frese A, et al. Members of the task force EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur J Neurol. 2006;13(6):560–572. PubMed

Musil F, Pokladnikova J, Pavelek Z, et al. Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial. Neuropsychiatr Dis Treat. 2018;14:1221–1228. PubMed PMC

Headache Classification Subcommittee of the International Headache Society (IHS) The international classification of headache disorders 3rd edition. Cephalagia. 2013;33:629–808. PubMed

Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20–S28. PubMed

Drummond MF, O’Brien BJ, Stoddart GL. Method for the Economic Evaluation of Healthcare Programmes. Oxford, UK: Oxford University Press; 1997.

Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998;13(1 Pt 1):1–7. PubMed

Wimo A, Reed CC, Dodel R, et al. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer’s disease in three European countries – study design and baseline findings. J Alzheimers Dis. 2013;36(2):385–399. PubMed

Pokladnikova J, Krcmova I, Vlcek J. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2008;100(5):482–489. PubMed

Maresova P, Klimova B, Novotny M, Kuca K. Alzheimer’s and Parkinson’s diseases: expected economic impact on Europe-a call for a uniform European strategy. J Alzheimers Dis. 2016;54(3):1123–1133. PubMed

WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2017. [Accessed September 23, 2018]. Available from: https://www.whocc.no/atc_ddd_index/

General Health Insurance Fund of the Czech Republic. [Accessed September 23, 2018]. Available from: https://www.vzp.cz/poskytovatele/ciselniky/zdravotni-vykony.

General Health Insurance Fund of the Czech Republic. [Accessed September 23, 2018]. Available from: https://www.vzp.cz/poskytovatele/ciselniky/hromadne-vyrabene-lecive-pripravky-a-potraviny-pro-zvlastni-lekarske-ucely/archiv.

Ministry of Labour and Social Affairs of the Czech Republic. [Accessed September 23, 2018]. Available from: http://www.mpsv.cz/cs/78.

CSU Czech Statistical Office. [Accessed September 23, 2018]. Available from: https://www.czso.cz/csu/czso/makroekonomika-fqhqlzbynt.

CSU Czech Statistical Office. [Accessed September 23, 2018]. Available from: http://www.czso.cz/csu/redakce.nsf/i/tab_2_ekonomika_a_infrastruktura_zu/File/2zu_eki.xls.

Heyse J, Cook J, Carides G. Statistical considerations in analysing healthcare resource utilization and cost data. In: Drummond M, McGuire A, editors. Economic Evaluation in Healthcare: Merging Theory with Practice. New York, NY: Oxford University Press; 2001. pp. 215–235.

Liguori A, Petti F, Bangrazi A, et al. Comparison of pharmacological treatment versus acupuncture treatment for migraine without aura-analysis of socio-medical parameters. J Tradit Chin Med. 2000;20(3):231–240. PubMed

Wonderling D, Vickers AJ, Grieve R, Mccarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004;328(7442):747. PubMed PMC

Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture treatment in patients with headache. Cephalalgia. 2008;28(4):334–345. PubMed